BrachyDOSE seed investment

Great news! BrachyDOSE received €554 000 seed investment. The deal includes Coinvest Capital, BSV Ventures, and business angels’ networks LitBAN and EstBAN.

This investment is a big step forward for us — it brings us closer to securing MDR (Medical Devices Regulation) and CE (Conformité Européenne) certifications and launching our product to the market.

BrachyDOSE is a patient-centric, data-driven measurement tool that helps doctors’ to prevent up to 100% of treatment-caused injuries in radiotherapy procedures. The solution is hardware and software combined. Hardware: a sensor for radiation dose measurement and a reading device for data retrieval after the procedure. Software: the injury prediction algorithm giving the decision support for a doctor.

Our co-founder and CEO of BrachyDOSE Neringa Šeperienė shares her excitement: “We are grateful to the venture funds and angel investors who have supported us on our journey. This investment is a major boost that empowers BrachyDOSE team to pursue our goal – to help cancer patients avoid the side effects of radiotherapy, while enabling hospitals and doctors significantly improve cancer treatment quality”. “Once we obtain CE/MDR certification, we will be able to offer our product to both Lithuanian and international markets.”

BrachyDOSE team would like to thank our investors for their support and trust.

Read more in other media channels:

• 15min.lt

• coinvest.lt